Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ADYNF is Revolutionizing Plant-Based Therapeutics for a Range of Ailments
Algae Dynamics Corp. (OTC: ADYNF) has developed a unique strategy of producing a variety of products that combine the health benefits of both algae and cannabis oils. The synergistic effects of the two plant-based remedies hold tremendous promise, and the ability to sell and cross market the products to health conscious consumers gives the company real competitive advantages. A recent NNW article highlights the company’s progress in this innovative endeavor and notes key partnerships established to achieve its corporate goals:
“With an ongoing commitment to science, Algae Dynamics has engaged two Canadian universities to perform research and product development into the use of extracts from cannabis oil combined with the proven health benefits of Omega-3s derived from algae oil. Research is focused on the use of cannabis oil and Omega-3s in treatment of cancers and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. Algae Dynamics is applying hard science to eons of plant-based medicine and human history to create unique and effective therapeutics that may very well may set a new standard in treating a multitude of ailments and propel the company far beyond expectations. With all that’s happening, it certainly appears that Algae Dynamics is fast on its way to realizing its vision of becoming a global leader in the formulation and development of health products from cannabis derivatives, algae oils and other botanical oils.”
To view the full article, visit http://nnw.fm/cD6h5
About Algae Dynamics
Algae Dynamics is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. To assist in this development, Algae Dynamics engaged two Canadian universities to provide research, focusing on the use of cannabis oil in the context of cancer and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. Algae Dynamics intends to utilize this research to develop products that combine the significant health benefits of Omega-3 fatty acids derived from algae oil with extracts from cannabis oil for the rapidly growing medical and non-medical markets in Canada and globally. The company has developed strategic relationships with licensed producers of cannabis to ensure a source of cannabis oil. Algae Dynamics’ product development efforts are designed in the near-term for over-the-counter nutraceuticals, and in the longer-term for patented medicines. The company’s recent initiatives are an extension of its previous plan, which was focused solely on commercialization of its proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. For more information, visit the company’s website at http://www.algaedynamics.com
ADYNF Changing the Dynamic of Plant Based Therapeutics
- Proprietary system for high volume, low cost production of medicinal algae
- New research on botanical oil products derived from both cannabis and algae
- Combined health benefits of cannabis and algae create new exclusive market
People have always relied on plants as a primary source of medicine and healing. Hundreds of remarkably common plants, herbs, and flowers continue to serve all kinds of important medicinal and health purposes. Various strains of algae offer high concentrations of vitamins, minerals, antioxidants and proteins. Brown algae have been used for weight loss, cancer, fibromyalgia, arthritis, stress, heart disease and high cholesterol. Blue-green algae, scientific studies indicate, offer antiviral, antitumor, antioxidant, anti-inflammatory, anti-allergic, antidiabetic, and antibacterial properties. Recognized as a powerful energy booster, blue-green algae are used for weight loss, hay fever, diabetes, stress, anxiety, depression, and to improve memory and digestive health.
With so many medically beneficial applications, its little wonder that Algae Dynamics Corp. (OTC: ADYNF) has focused on commercialization of its proprietary BiloSilo™ system for the high volume, low cost production of contaminant-free algae biomass. These cost-effective, highly-pure algae biomasses are rich in minerals, prebiotics, vitamins, and other nutritional substances and are exceptionally high in Omega-3 fatty acids, which can be added to a wide range of products. Algae Dynamics’s unique nutraceutical algae oil health products have now expanded to include pharmaceutical cannabis oils. Algae Dynamics has developed a vegetal strategy of producing products that combine the health benefits of both algae and cannabis oils. The synergistic effects of the two plant-based remedies hold tremendous promise, and the ability to sell and cross market the products to health conscious consumers gives the company real competitive advantages.
With an ongoing commitment to science, Algae Dynamics has engaged two Canadian universities to perform research and product development into the use of extracts from cannabis oil combined with the proven health benefits of Omega-3’s derived from algae oil. Research is focused on the use of cannabis oil and Omega-3’s in treatment of cancers and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health.
Algae Dynamics is applying hard science to eons of plant-based medicine and human history to create unique and effective therapeutics that may very well may set a new standard in treating a multitude of ailments and propel the company far beyond expectations. With all that’s happening, it certainly appears that Algae Dynamics is fast on its way to realizing its vision of becoming a global leader in the formulation and development of health products from cannabis derivatives, algae oils and other botanical oils. New therapeutics from ancient remedies would seem certain to be embraced in the marketplace.
For more information, visit the company’s website at www.AlgaeDynamics.com
ADYNF Poised for Expansion into Canadian Cannabis Oil Market
- The Government of Canada expects to fully legalize marijuana nationwide by July 2018
- The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020
- Algae Dynamics Corp. is uniquely positioned to enter the Canadian cannabis oil market with its experience in algae oil extraction
- Algae Dynamics will capitalize on the under-served Canadian cannabis oil marketplace
Algae Dynamics Corp. (OTCQB: ADYNF) is uniquely positioned to take advantage of the full legalization of cannabis in Canada by leveraging its expertise and experience with algae oil extraction to expand into the Canadian cannabis oil marketplace. While Algae Dynamics is publicly traded in the U.S., its business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis.
The original core of the company’s product development was extraction of Omega-3 fatty acids from algae with high concentrations of DHA for nutraceutical products. The company plans to leverage its oil extraction expertise in the cannabis oil extraction marketplace.
Due to the many demonstrated health benefits of both algae and cannabis oils, Algae Dynamics is now targeting a strategy to develop products combining the health benefits of both oils. Part of Algae Dynamics’ strategy is to research the possibility that combining certain algae and cannabis oils may have an enhanced effect for users.
An under-served market for licensed producers in Canada offers great opportunity for Algae Dynamics. Currently there are only 50 licensed producers in all of Canada, which has a population of 35 million – roughly the size of California. In contrast, in Colorado, there are now 624 licensed cultivators. Recreational use of cannabis in Colorado has been legal for adults since 2012.
The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020 – more than a 1,000-fold increase. Capitalizing on the growing demand for cannabis oil and other smoke-free alternatives to cannabis consumption will help support ongoing Algae Dynamics initiatives to create and market research-driven product formulations. Research shows that, in Colorado, 45% of the users of dried cannabis will eventually convert to the use of extracts including oils. Similar trends are expected in Canada, thus expanding the market for cannabis oil.
Collaborations with the University of Waterloo and the University of Western Ontario will use university-level research for creating cannabis oil product lines, which could provide treatment for several types of cancer, as well as depression, post-traumatic stress disorder, anxiety, and schizophrenia. Algae Dynamics will retain rights to any patents developed in collaboration with university research.
Algae Dynamics is led by a strong management team. Co-founder and CEO Richard Rusiniak brings more than 30 years of management, design and process experience. Rusiniak is the co-founder and former president, CFO and CTO of Cymat Corp. (TSX: CYM), which had a market valuation of more than $150 million when he left in 2002. Co-founder and President Paul Ramsay has more than 25 years of business development and management experience. Ramsay co-founded Cymat Corp. with Rusiniak and served as CEO and vice president of business development.
Ross Eastley serves as CFO, and Algae Dynamics’ board of directors includes P. Blair Mullin, managing partner of Apollo Ventures, Aldercreek Capital LLC, and Apollo Marketing LLC, which provide investment capital to emerging companies. Cameron McDonald, CEO of Coldwater Fisheries Inc., a leading Canadian aquaculture company, also serves on the board.
For more information about the company’s research efforts and development process, go to www.AlgaeDynamics.com
ADYNF Management at a Glance
As part of its strategy to become the No. 1 research Canadian cannabis oil research-driven product formulator, Algae Dynamics’ management team has assembled a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. These advisors include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.
Algae Dynamics' executive management team is as follows:
Co-founder and CEO Richard Rusiniak is a mechanical engineer with more than 30 years of management design and process experience. He is also the co-founder and former president, CFO and CTO of Cymat Corp (TSX: CYM), which had a market valuation over $150 million upon his resignation in 2002. Previous accomplishments include the negotiation of an Aluminum Foam Manufacturing license with Alcan International Ltd., and the successful commercialization of the technology. Rusiniak also completed a $10 million technology development program with Industry Canada (TPC), and participated in the completion of $25 million in financing with financial institutions.
Co-founder and president Paul Ramsay (BBA) brings more than 25 years of business development and management experience to the table. As the co-founder and former CEO and VP Business Development of Cymat Corp, (TSX: CYM), Ramsay was instrumental in securing the Stabilized Aluminum Foam (SAF) license from Alcan International Ltd., among other achievements.
Algae Dynamics CFO Ross Eastley (CA) has more than 30 years of accounting and CFO experience in the private and public sectors. He was formerly the CEO of the Canadian Society of Immigration Consultants (2006 – 2009), where he reported to a nine-member board and was responsible for strategic planning, corporate communications, initial regulatory functions and management of legal processes.
For more information, visit www.algaedynamics.com
ADYNF Continues Cannabis Oil Research as Potential Marijuana Shortage Looms in Canada
- A 1,000-fold increase in the Canadian cannabis oil extraction market is expected, with growth from C$1 million in 2015 to an expected C$1.7 billion by 2020
- The Canadian market is expected to see a conversion rate of 45 percent, which is similar to trends in Colorado, based on a Mackie Research Capital study
- The Government of Canada expects to fully legalize marijuana nationwide on or before July 2018
Investors have had their eyes on Algae Dynamics Corp. (OTCQB: ADYNF), which has partnered with various Canadian universities (including the University of Waterloo and Western University) for access to research and to boost its cannabis extraction expertise. The company is now positioned to serve the medical and recreational marijuana markets. However, many are surprised to learn that, as legalization of recreational marijuana is set for July 2018, Charles Sousa, Ontario’s finance minister, has warned of a possible supply shortage.
The company has had at the core of its product development strategy the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA, which is an important nutrient for brain, eye, and heart health, as well as the creation of various associated nutraceutical products. In light of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, the company has developed a strategy aimed at developing new products combining the health benefits of algae and cannabis oils.
In a Bloomberg Politics article (http://nnw.fm/DfXQ2), an analyst suggested a supply shortage could give the government an excuse to delay the country’s marijuana program, even as the cannabis oil extraction market grows toward the billion-dollar mark. Government officials, however, have made it clear they want a supply that’s able to accommodate demand to bring down organized crime and illicit drug use. The initial plan is expected to allow sales of cannabis online and via mail.
The reasons for a potential shortage include difficulty in stocking enough inventory nationwide, expanding patient lists, and producers selling out of strains or refusing to take on new clients. In Canada, the number of registered medical marijuana users tripled in one year, and the medical market is already seeing shortages. Health Canada announced in May that it would expedite the license approval process. New licenses have been issued, but it can take a year or more for businesses to build up production. Recent studies have shown a 45 percent conversion rate (users of dry marijuana switching to cannabis oil products) in Colorado, which is anticipated in Canada as well. Licensing and expertise will be needed to meet this demand.
Despite uncertainties, demand and research and development in the cannabis market continue to surge. As Algae Dynamics aims to be the leader in cannabis oil research in Canada, it continues to pursue the compound as a treatment for conditions such as colorectal, breast, pancreatic, and prostate cancers, and for other conditions such as post-traumatic stress disorder, schizophrenia, anxiety, and depression. The company itself will submit a licensing application to Health Canada, so it can produce medical marijuana and sell cannabinoid-derived products. Its knowledge and cultivation know-how enables production of an algae biomass that is free of contaminants and high in healthy Omega-3 fatty acids.
The management, fundraising, process, and commercialization experience of the Algae Dynamics team has positioned the company for rapid growth. Despite the threat of a legalized marijuana supply shortage, the company is working hard with researchers, developers, and investors in a market that encompasses all of Canada and that extends well beyond the country’s borders.
For more information about the company’s research efforts and development process, go to www.AlgaeDynamics.com
ADYNF Targets Nutraceutical Market Leveraging Health and Efficacy Effects of Algae-Cannabis Oils
The nutraceutical industry boasts a diversified playing field, and Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is taking a unique approach to this burgeoning market, focusing on the development of proprietary research and products that combine the health benefits of botanical oils derived from cannabis and algae. “The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations. Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.”
To view the full article, visit: http://nnw.fm/LKsZ1
About Algae Dynamics
Algae Dynamics is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. To assist in this development, Algae Dynamics engaged two Canadian universities to provide research, focusing on the use of cannabis oil in the context of cancer and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. Algae Dynamics intends to utilize this research to develop products that combine the significant health benefits of Omega-3 fatty acids derived from algae oil with extracts from cannabis oil for the rapidly growing medical and non-medical markets in Canada and globally. The company has developed strategic relationships with licensed producers of cannabis to ensure a source of cannabis oil. Algae Dynamics’ product development efforts are designed in the near-term for over-the-counter nutraceuticals, and in the longer-term for patented medicines. The company’s recent initiatives are an extension of its previous plan, which was focused solely on commercialization of its proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. For more information, visit the company’s website at http://www.algaedynamics.com
ADYNF is “One to Watch”
Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.
The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.
Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.
Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market’s attractiveness can be further realized when considering that the Canada’s licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.
Collaborating with prominent Canadian universities is a core part of the Algae Dynamics’ plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.
Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.
As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company’s initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.
With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market.
For more information, visit the company’s website at www.AlgaeDynamics.com
Nice bounce today. Does anyone know what's happening with this stock at the moment?
Revised business strategy, now in the cannabis industry.
http://www.algaedynamics.com/
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11961637
Will keep my eye on this one as well. Seems like a thin market, hit $1.40 on just a few thousand shares traded on Tuesday.
As previously announced the Company has entered into a $750,000 Equity Purchase Agreement with RY Capital Group, LLC pursuant to which, subject to the terms and conditions thereof, the Company can put shares to RY to fund future development and general working capital requirements.
Paul Ramsay, Chairman and President of ADYNF said, "We are pleased to provide this timely update on our business. As we continue to work with scientists at the University of Waterloo, including Dr. Kirsten Muller, one of the world's leading phycologists, we now have the essential elements in place with which to execute our business plan. We expect developments to escalate quite rapidly."
http://finance.yahoo.com/news/algae-dynamics-corp-provides-corporate-142900068.html
There's a big demand for Chlorella in North America, yet there are no commercial North American producers of it. ADYNF plans to fill that gap! ~ http://www.algaedynamics.com/markets.php
So thin on the Ask...
Just add some news, some buying, and it could really Go!
http://www.otcmarkets.com/stock/ADYNF/quote
Would like to see an update soon about their integrated BioSilo® manufacturing system, which provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our “controlled outcomes” technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil. For more information visit: http://www.algaedynamics.com
$ADYNF
Key milestones that position ADYNF for future development:
- Equipment fully sourced and ready to order, subject to available financing.
- Production facility in Mississauga, Ontario fully built-out and clean room ready for delivery of production scale cultivation vessels.
- Trading symbol obtained stock listed on OTCmarkets.com as an OTC Pink stock trading under the ticker symbol "ADYNF".
- Full-service eligibility with both DTC (Depository Trust Company) in the United States and CDS (Canadian Depository for Stocks).
- And, as previously announced the Company has entered into a $750,000 Equity Purchase Agreement with RY Capital Group, LLC pursuant to which, subject to the terms and conditions thereof, the Company can put shares to RY to fund future development and general working capital requirements.
Paul Ramsay, Chairman and President of the Company said, "We are pleased to provide this timely update on our business. As we continue to work with scientists at the University of Waterloo, including Dr. Kirsten Muller, one of the world's leading phycologists, we now have the essential elements in place with which to execute our business plan. We expect developments to escalate quite rapidly."
http://finance.yahoo.com/news/algae-dynamics-corp-provides-corporate-142900068.html
yeah, I saw that and totally agree. Their total outstanding is really tight as well, only 9.75 million.
ADYNF announced that its S-1 Registration Statement filing has been declared effective by the Securities & Exchange Commission as of March 3, 2016.
The purpose of the S-1 is to register for resale 400,000 common shares that are subject to the Equity Purchase Agreement signed with RY Capital Group in September 2015 that was previously announced. In addition, certain other shares owned by shareholders of the Company were registered for resale. The registration of the shares pursuant to the EPA permit the Company to sell shares to RY, and RY is obligated to buy such shares, subject to the terms and conditions of the Equity Purchase Agreement. Accordingly, the Company provided a notice in accordance with the terms of the EPA to sell 64,103 shares to RY for gross proceeds of US$62,500 on March 3, 2016.
Paul Ramsay, Chairman and President of the Company said, "We are pleased to announce that the Equity Purchase Agreement made available to us by RY is now active and funding is available. Such funding provides the Company with flexibility in proceeding with our business plan. These funds give us increased flexibility to complete a larger capital raise which we need in order to fully execute on our business plan, as described in our public filings."
http://finance.yahoo.com/news/algae-dynamics-corp-announces-effectiveness-133500400.html
Algae Dynamics will target two key segments of the functional food and additive sector: Chlorella and Omega-3.
Despite a market for Chlorella in North America, there are no commercial North American producers of it.
http://www.algaedynamics.com/markets.php
$ADYNF
Volume is picking up a little bit!...
Only a matter of time before this gem gets noticed...
GLTA! ~ $ADYNF
Tiny Float here ~ Only 1.27 Million shares!
Check out Level 2 ~ It's super thin on the Ask side
http://www.otcmarkets.com/stock/ADYNF/profile
$ADYNF
Nice looking Bottom-Bouncer Play here!
Looking to grab some ADYNF cheapies at these prices...
GLTA! ~ $ADYNF
Despite a market for Chlorella in North America, there are no commercial North American producers of it. ADYNF plans to fill that niche!
If good news hits, any buy volume could send this one flying!
The Ask side on Level 2 is super thin on ADYNF
ADYNF is a development stage company focused on the commercialization of its proprietary BioSilo™ Cultivation System that grow algae strains for use in the food and health supplement industry. Fore more information visit: http://www.algaedynamics.com
Algae Dynamics intends to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil. Their integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, their “controlled outcomes” technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. For more information visit: http://www.algaedynamics.com/markets.php
ADYNF
$ADYNF basic chart ## source: stockscores.com
$ADYNF DD Notes ~ http://www.ddnotesmaker.com/ADYNF
Watching for a possible oversold bounce from current level
ADYNF
$ADYNF ~ Algae Dynamics Corp. due diligence report
$ADYNF DD Notes ~ http://www.ddnotesmaker.com/ADYNF
Algae Dynamics integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our “controlled outcomes” technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil. For more information visit: http://www.algaedynamics.com
ADYNF
ADYNF has an impressive list of Private Investors and Funding Partners!
http://www.algaedynamics.com/funding-partners.php
Algae Dynamics integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our “controlled outcomes” technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil. For more information visit: http://www.algaedynamics.com
Algae Dynamics Corp. Announces OTCQB Application
http://finance.yahoo.com/news/algae-dynamics-corp-announces-otcqb-140000394.html
ADYNF
ADYNF is currently engaged in the commercialization of our proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass. This biomass is high in Omega-3s DHA/DPA, vitamins, minerals and antioxidants, all of which are in demand by the growing multibillion dollar food/beverage and health care sectors.
Algae Dynamics integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our “controlled outcomes” technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil. For more information visit: http://www.algaedynamics.com
Algae Dynamics Corp Provides Corporate Update
http://finance.yahoo.com/news/algae-dynamics-corp-provides-corporate-142900068.html
Check out the Algae Dynamics website:
http://www.algaedynamics.com
ADYNF is a OTCQB trading at $1.59 with Free Level 2
http://www.otcmarkets.com/stock/ADYNF/quote
This one is thin on the Ask side
Algae Dynamics Financing Update! Read our expose!
Algae Dynamics Death Spiral Financing Announced by Chapter 7 Bankrupt NY Blinds Installer
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
93
|
Created
|
07/29/15
|
Type
|
Free
|
Moderators |
Volume: | 5,000 |
Day Range: | 0.02 - 0.02 |
Last Trade Time: | 3:49:52 PM EST |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads